House bill could expand Chesapeake blue catfish use in pet food: full analysis

A bill that would open a federally supported pathway for invasive Chesapeake Bay blue catfish to enter pet food is moving in Washington, and it’s drawing scrutiny well beyond fisheries policy. The MAWS Act, led by Rep. Sarah Elfreth and co-led by Rep. Rob Wittman, passed the House in March 2026 after being introduced in July 2025. Its core purpose is to create a NOAA-run pilot program that helps manufacturers and processors buy blue catfish harvested from the Chesapeake Bay watershed for use in pet food, animal feed, and aquaculture feed. (elfreth.house.gov)

The policy grew out of a long-running Chesapeake Bay problem. Blue catfish were introduced decades ago, spread far beyond the freshwater systems where managers expected them to remain, and are now widely viewed by federal and regional officials as a serious invasive threat. House materials tied to the bill say the fish prey on native species including blue crabs, American shad, and striped bass, and describe the pilot as a way to support commercial removal while studying ecological effects and market development. The committee background also says the program would run for three years, from January 1, 2027, through December 31, 2029, followed by a report to Congress within 180 days. (seafoodsource.com)

What changed is not pet food law itself, but the prospect of a new federally encouraged ingredient stream. The bill defines “covered entities” broadly enough to include businesses manufacturing or processing pet food, animal feed, or aquaculture feed. It would allow federal funds to support purchases of blue catfish from watermen and seafood processors, with up to 15% of funds available to offset transportation costs. In floor debate, Elfreth argued the program would create a sustainable outlet for fish outside the preferred size range for human consumption, especially very small and very large fish. That point matters because state environmental agencies have separately warned that contaminant risk in blue catfish is not uniform: Maryland says the species can bioaccumulate PCBs and mercury, with advisories that vary by size and by where the fish was caught, and larger fish over 30 inches are a particular human-consumption concern. (congress.gov)

That’s where the safety debate becomes more relevant to veterinary readers. FDA states that pet food must be safe and contain no harmful substances, and that the agency routinely tests animal food for toxic trace elements such as mercury. At the same time, FDA says there are no tolerances or other administrative levels established for dioxins in animal food, and points manufacturers and regulators to temporary PCB tolerances in 21 CFR 509.30. That regulation includes temporary tolerances for PCB residues in certain animal-feed categories, including animal-origin feed components such as fishmeal and other marine by-products, but it does not amount to a pet-food-specific contaminant framework for Chesapeake Bay blue catfish. (fda.gov)

The original source framing from Truth about Pet Food argues the bill would allow fish contaminated with PCBs and mercury into pet food “with no safety considerations in place for pets.” That overstates what the legislation itself says: the bill does not waive FDA safety law or create a contaminant exemption. But the criticism does point to a real gap. The MAWS Act is principally a market-making and ecosystem-management bill, not a contaminant-control bill, and the available legislative text does not appear to add species-specific testing requirements, contaminant caps, or disclosure rules for blue catfish destined for pet food. The consumer concern is not abstract. Maryland advisories cited by critics note that some waterways carry stricter limits than others and that fish over 30 inches are generally discouraged for human consumption because contaminants accumulate over time; state guidance has also noted that removing fatty dark meat or belly flap can substantially reduce PCB exposure in fish prepared for people. None of that automatically translates into pet food risk, but it does sharpen the practical questions veterinarians and buyers may ask about sourcing, fish size, trimming, and processing. EPA, meanwhile, continues to advise consumers to check state and local fish advisories because locally caught fish may carry contaminant concerns, including mercury. (truthaboutpetfood.com)

Industry reaction has been mixed. SeafoodSource reported that the Pet Food Institute endorsed the legislation, suggesting at least some pet food stakeholders see value in a new protein stream tied to invasive-species management. Truth about Pet Food also said the Animal Feed Industry Association supported the measure. But opposition surfaced from a coalition of Maryland blue catfish processors, whose March 12, 2026 letter was entered into the Congressional Record. Their concern was less about toxicology than market signaling: they argued that emphasizing pet food could undermine efforts to build blue catfish as a human food product and distort an emerging private market that already uses some byproducts in rendering and pet food. (seafoodsource.com)

Why it matters: Veterinary teams may increasingly get questions from pet parents about fish-based diets, contaminants, and sourcing transparency if Chesapeake blue catfish starts appearing more often in labels or marketing copy. The clinical issue is chronic exposure, not acute toxicity headlines. FDA notes that long-term effects from methylmercury depend on dose, frequency, duration, and the characteristics of the consumer, and its animal food program treats mercury, lead, cadmium, and arsenic as toxic trace elements worth monitoring. For veterinarians, that means this story sits at the intersection of nutrition, toxicology, and client communication: if new fish ingredients enter the market, practitioners may want clearer answers on batch testing, sourcing geography, harvest location, species size, whether higher-fat portions were removed before processing, rendering practices, and whether formulations are intended for intermittent or complete-and-balanced feeding. (fda.gov)

What to watch: The next key questions are whether the Senate takes up H.R. 4294, whether NOAA’s eventual pilot design adds any contaminant-screening expectations, and whether FDA or state feed regulators weigh in on how existing adulteration and contaminant rules apply to Bay-caught blue catfish used in pet food before the pilot’s scheduled 2027 launch. It will also be worth watching whether manufacturers voluntarily disclose catch area, fish size, or ingredient form — for example, whole fish versus fish meal — as they respond to questions about contaminant control and sourcing transparency. (congress.gov)